Bank of Montreal Can decreased its holdings in shares of Phibro Animal Health Corp (NASDAQ:PAHC) by 4.0% during the first quarter, Holdings Channel reports. The institutional investor owned 93,658 shares of the company’s stock after selling 3,911 shares during the period. Bank of Montreal Can’s holdings in Phibro Animal Health were worth $3,091,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Advisory Services Network LLC grew its stake in shares of Phibro Animal Health by 20.4% during the fourth quarter. Advisory Services Network LLC now owns 2,195 shares of the company’s stock valued at $71,000 after buying an additional 372 shares during the last quarter. Victory Capital Management Inc. grew its stake in Phibro Animal Health by 4.1% in the fourth quarter. Victory Capital Management Inc. now owns 10,756 shares of the company’s stock worth $346,000 after purchasing an additional 419 shares in the last quarter. Algert Global LLC grew its stake in Phibro Animal Health by 1.6% in the fourth quarter. Algert Global LLC now owns 28,849 shares of the company’s stock worth $928,000 after purchasing an additional 464 shares in the last quarter. Texas Permanent School Fund grew its stake in Phibro Animal Health by 4.5% in the fourth quarter. Texas Permanent School Fund now owns 13,225 shares of the company’s stock worth $425,000 after purchasing an additional 564 shares in the last quarter. Finally, Advisors Asset Management Inc. grew its stake in Phibro Animal Health by 52.3% in the fourth quarter. Advisors Asset Management Inc. now owns 2,536 shares of the company’s stock worth $82,000 after purchasing an additional 871 shares in the last quarter. 50.88% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NASDAQ:PAHC opened at $28.46 on Thursday. Phibro Animal Health Corp has a 52-week low of $28.28 and a 52-week high of $54.62. The company has a market capitalization of $1.16 billion, a P/E ratio of 16.36, a PEG ratio of 4.25 and a beta of 0.63. The company has a current ratio of 3.41, a quick ratio of 1.98 and a debt-to-equity ratio of 1.48.
Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Monday, May 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($0.04). Phibro Animal Health had a return on equity of 33.77% and a net margin of 8.12%. The firm had revenue of $205.70 million during the quarter, compared to the consensus estimate of $214.94 million. During the same period last year, the company earned $0.46 EPS. The firm’s revenue for the quarter was down 1.5% compared to the same quarter last year. As a group, equities research analysts predict that Phibro Animal Health Corp will post 1.52 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Wednesday, June 5th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a $0.48 annualized dividend and a yield of 1.69%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 27.59%.
Several research analysts recently issued reports on the company. Zacks Investment Research raised Phibro Animal Health from a “sell” rating to a “hold” rating in a research note on Wednesday, January 23rd. BidaskClub raised Phibro Animal Health from a “sell” rating to a “hold” rating in a research note on Friday, March 22nd. ValuEngine cut Phibro Animal Health from a “hold” rating to a “sell” rating in a research note on Wednesday, February 13th. Finally, Gabelli raised Phibro Animal Health from a “hold” rating to a “buy” rating and set a $42.00 price objective on the stock in a research note on Wednesday, May 8th. They noted that the move was a valuation call. Three research analysts have rated the stock with a sell rating, one has issued a hold rating and two have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $43.50.
COPYRIGHT VIOLATION NOTICE: This piece was published by Macon Daily and is the sole property of of Macon Daily. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://macondaily.com/2019/05/16/bank-of-montreal-can-has-3-09-million-stake-in-phibro-animal-health-corp-pahc.html.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Recommended Story: Fiduciary
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.